A Multi-Organ Atlas Links Gut Microbial Metabolites To Systemic Redox Changes In Aging Mice
As we age, our bodies undergo numerous changes, and a key player in this process appears to be the tiny inhabitants of our gut: microbes. Recent research has shed light on how these gut microbes and the substances they produce, called metabolites, contribute to the aging process throughout the entire body.
Scientists conducted a comprehensive study across multiple organs in mice, including the gut, blood, liver, lungs, and brain, to understand how aging affects metabolism. They discovered a consistent pattern associated with aging: a reduction in beneficial circulating metabolites, such as lysophosphatidylcholines (LPCs), and a simultaneous increase in harmful, pro-oxidative microbial byproducts like trimethylamine N-oxide (TMAO) and indole-3-acetic acid (IAA).
This imbalance, often referred to as a “microbial-metabolic drift,” disrupts how fats are transported and how the body manages oxidative stress, which is an imbalance between free radicals and antioxidants.
The consequences of this metabolic shift are far-reaching, leading to distinct vulnerabilities in different organs. For instance, the liver showed increased fat retention and a higher susceptibility to ferroptosis, a type of iron-dependent cell death. The lungs experienced immune-redox activation, and the brain exhibited dysregulation in its neurochemicals.
Further analysis, integrating findings from many other independent studies, reinforced the idea that changes in the gut microbiome are functionally linked to systemic aging. These findings suggest that the metabolic reprogramming driven by gut microbes is a modifiable factor in systemic aging, offering promising avenues for developing new therapies to promote healthier aging.
Source: link to paper